Key Highlights

  • H.B. Fuller's $0.2450 quarterly dividend has an October 15, 2026 ex-dividend date and is payable October 29 to shareholders of record.
  • Third-quarter net revenue was $938 million, up 5.2%, with organic revenue up 4.4% and reported diluted EPS of $1.44.
  • Adjusted diluted EPS was $1.52, up 21%, and adjusted EBITDA was $187 million, a record 19.9% margin.
  • Fiscal 2026 adjusted diluted EPS guidance is $4.70 to $4.85, and adjusted EBITDA guidance is $655 million to $670 million.

H.B. Fuller's (NYSE:FUL) $0.2450 quarterly dividend yields 1.94% and sits beside third-quarter reported diluted EPS of $1.44 and adjusted diluted EPS of $1.52. The board declared it on October 1, 2026. In the first nine months of fiscal 2026 the company paid $39.1 million in dividends.

Dividend Program and Shareholder Returns

H.B. Fuller's board declared a regular quarterly cash dividend of $0.2450 per share on October 1, 2026, payable October 29 to shareholders of record at the close of business on October 15.

In April 2026 the board increased the quarterly dividend from $0.2350 to $0.2450. The company paid $39.1 million in dividends in the first nine months of fiscal 2026 versus $37.6 million a year earlier, and repurchased $48.9 million of common stock versus $60.7 million.

About the Company

H.B. Fuller describes itself as the largest pureplay adhesives company in the world. Founded in 1887 and based in St. Paul, Minnesota, it had 2025 revenue of $3.5 billion and more than 7,100 team members serving more than 30 market segments in 150 countries.

Financial Performance Behind the Payout

For the third quarter ended August 29, 2026, net revenue was $938 million, up 5.2%. Pricing increased net revenue by 7.4%, more than offsetting a 3.0% volume decline, for organic revenue growth of 4.4% in all three global business units. Currency and acquisitions added 0.7% and 0.1%.

Gross profit was $312 million, a 33.2% margin, and adjusted gross profit was $315 million, a 33.5% margin, up 120 basis points. Net income attributable to the company was $79 million versus $67 million. Reported diluted EPS was $1.44 versus $1.22, and adjusted diluted EPS was $1.52 versus $1.26. Adjusted net income was $83 million.

Adjusted EBITDA was $187 million, up 9%, a record margin of 19.9%, up 80 basis points. Net debt was $1,957 million, and net debt to adjusted EBITDA was 3.0x versus 3.3x. Net working capital was 18.5% of annualized net revenue, up 150 basis points, which the company attributed to inventory investments, and nine-month cash flow from operations was $183 million, up 17%.

The AMS Acquisition and Financing

The company's chief executive officer referred to the anticipated closing of the Advanced Medical Solutions acquisition before year-end. The release shows a $19.7 million unrealized gain on a foreign exchange forward contract related to the pending acquisition, and $7.8 million of debt extinguishment and bridge financing costs tied to an acquisition. The company priced $850 million of 7.625% senior unsecured notes due 2034 for that purpose, of which $450 million must be redeemed if the acquisition is not completed by June 25, 2027.

Outlook

H.B. Fuller's fiscal 2026 guidance is adjusted EBITDA of $655 million to $670 million, adjusted diluted EPS of $4.70 to $4.85 and cash flow from operations, excluding AMS-related items, of $300 million to $325 million. Net revenue is guided up mid-single digits, with a core tax rate of 25.5% to 26.0%.